Cellular plasticity: The good, the bad, and the ugly? microenvironmental influences on progenitor cell therapy

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 3, 2012, Pages 275-285

  Moonen, Jan Renier A J ^a   Harmsen, Martin C ^a   Krenning, Guido ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiovascular disease; Cell therapy; Cyclic strain; Endothelial progenitor cell; Endothelial mesenchymal transition; Fluid shear stress; Inflammation; Mechanotransduction; Microenvironment; Plasticity

Indexed keywords

CELL DIFFERENTIATION; CELL FUNCTION; CELL STRESS; CELL THERAPY; ENDOTHELIAL PROGENITOR CELL; HEALING; HEART MUSCLE INJURY; MECHANOTRANSDUCTION; MICROENVIRONMENT; PLASTICITY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; ENDOTHELIAL CELLS; HUMANS; MYOCARDIAL INFARCTION; SHEAR STRENGTH; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84858020996     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-107     Document Type: Review

References (106)

1. Abbott, J.D., Huang, Y., Liu, D., Hickey, R., Krause, D.S., and Giordano, F.J. 2004. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation, 110(21): 3300-3305. doi:10.1161/01.CIR. 0000147780.30124.CF
2. Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 100(2): 158-173. doi:10.1161/01.RES.0000255691.76142.4a
3. Akita, T., Murohara, T., Ikeda, H., Sasaki, K., Shimada, T., Egami, K., and Imaizumi, T. 2003. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab. Invest. 83(1): 65-73.
4. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302): 964-967. doi:10.1126/science.275.5302.964.
5. Berry, M.F., Engler, A.J., Woo, Y.J., Pirolli, T.J., Bish, L.T., Jayasankar, V., et al. 2006. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. 290(6): H2196-H2203. doi:10.1152/ajpheart.01017.2005.
6. Bonaros, N., Rauf, R., Werner, E., Schlechta, B., Rohde, E., Kocher, A., et al. 2008. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure. Interact. Cardiovasc. Thorac. Surg. 7(2): 249-255. doi:10.1510/icvts.2007.162917.
7. Boon, R.A., Urbich, C., Fischer, A., Fontijn, R.D., Seeger, F.H., Koyanagi, M., et al. 2011. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. Eur. Heart J. 32(3): 371-377. doi:10.1093/eurheartj/ehq137.
8. Burkholder, T.J. 2007. Mechanotransduction in skeletal muscle. Front. Biosci. 12(1): 174-191. doi:10.2741/2057.
9. Campos, L.C., Miyakawa, A.A., Barauna, V.G., Cardoso, L., Borin, T.F., Dallan, L.A., and Krieger, J.E. 2009. Induction of CRP3/MLP expression during vein arterialization is dependent on stretch rather than shear stress. Cardiovasc. Res. 83(1): 140-147. doi:10.1093/cvr/cvp108.
10. Cheng, K., Li, T.S., Malliaras, K., Davis, D.R., Zhang, Y., and Marban, E. 2010. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ. Res. 106(10): 1570-1581. doi:10.1161/CIRCRESAHA.109.212589.
11. Coomes, S.M., and Moore, B.B. 2010. Pleiotropic effects of transforming growth factor-beta in hematopoietic stem-cell transplantation. Transplantation, 90(11): 1139-1144. doi:10.1097/TP.0b013e3181efd018.
12. Cuccuini, W., Poitevin, S., Poitevin, G., Dignat-George, F., Cornillet-Lefebvre, P., Sabatier, F., and Nguyen, P. 2010. Tissue factor upregulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro. J. Thromb. Haemost. 8(9): 2042-2052. doi:10.1111/j.1538-7836.2010.03936.x.
13. Danoviz, M.E., Nakamuta, J.S., Marques, F.L., dos Santos, L., Alvarenga, E.C., dos Santos, A.A., et al. 2010. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS ONE, 5(8): e12077. doi:10.1371/journal.pone.0012077.
14. Desouza, C.V., Hamel, F.G., Bidasee, K., and O'Connell, K. 2011. Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes, 60(4): 1286-1294. doi:10.2337/db10-0875.
15. Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., et al. 2005. CCL2/Monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96(8): 881-889. doi:10.1161/01.RES.0000163017.13772.3a.
16. Di Nardo, P., Forte, G., Ahluwalia, A., and Minieri, M. 2010. Cardiac progenitor cells: potency and control. J. Cell. Physiol. 224(3): 590-600. doi:10.1002/jcp.22165.
17. Duncan, R.L., and Turner, C.H. 1995. Mechanotransduction and the functional response of bone to mechanical strain. Calcif. Tissue Int. 57(5): 344-358. doi:10.1007/BF00302070.
18. Engler, A.J., Sen, S., Sweeney, H.L., and Discher, D.E. 2006. Matrix elasticity directs stem cell lineage specification. Cell, 126(4): 677-689. doi:10.1016/j.cell.2006.06.044.
19. Engler, A.J., Carag-Krieger, C., Johnson, C.P., Raab, M., Tang, H.Y., Speicher, D.W., et al. 2008. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J. Cell Sci. 121(22): 3794-3802. doi:10.1242/jcs.029678.
20. Frangogiannis, N.G. 2004. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 53(11): 585-595. doi:10.1007/s00011-004-1298-5.
21. Fukata, Y., Amano, M., and Kaibuchi, K. 2001. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22(1): 32-39. doi:10.1016/S0165-6147(00)01596-0.
22. Ghazanfari, S., Tafazzoli-Shadpour, M., and Shokrgozar, M.A. 2009. Effects of cyclic stretch on proliferation of mesenchymal stem cells and their differentiation to smooth muscle cells. Biochem. Biophys. Res. Commun. 388(3): 601-605. doi:10.1016/j.bbrc.2009.08.072.
23. Gimble, J.M., Katz, A.J., and Bunnell, B.A. 2007. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100(9): 1249-1260. doi:10.1161/01.RES.0000265074.83288.09.
24. Glagov, S., Zarins, C., Giddens, D.P., and Ku, D.N. 1988. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch. Pathol. Lab. Med. 112(10): 1018-1031.
25. Goussetis, E., Manginas, A., Koutelou, M., Peristeri, I., Theodosaki, M., Kollaros, N., et al. 2006. Intracoronary infusion of CD133+and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infracted area, and body distribution. Stem Cells, 24(10): 2279-2283. doi:10.1634/stemcells.2005-0589.
26. Hamilton, D.W., Maul, T.M., and Vorp, D.A. 2004. Characterization of the response of bone marrow-derived progenitor cells to cyclic strain: implications for vascular tissue-engineering applications. Tissue Eng. 10(3-4): 361-369. doi:10.1089/107632704323061726.
27. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., et al. 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109(13): 1615-1622. doi:10.1161/01.CIR.0000124476.32871.E3.
28. Hiesinger, W., Frederick, J.R., Atluri, P., McCormick, R.C., Marotta, N., Muenzer, J.R., and Woo, Y.J. 2010. Spliced stromal cellderived factor-1alpha analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction. J. Thorac. Cardiovasc. Surg. 140(5): 1174-1180. doi:10.1016/j.jtcvs.2010.08.012.
29. Hoffman, B.D., Grashoff, C., and Schwartz, M.A. 2011. Dynamic molecular processes mediate cellular mechanotransduction. Nature, 475(7356): 316-323. doi:10.1038/nature10316.
30. Hung, H.S., Chen, H.C., Tsai, C.H., and Lin, S.Z. 2011. Novel approach by nanobiomaterials in vascular tissue engineering. Cell Transplant. 20(1): 63-70. doi:10.3727/096368910X532864.
31. Ingber, D.E. 1997. Tensegrity: the architectural basis of cellular mechanotransduction. Annu. Rev. Physiol. 59(1): 575-599. doi:10.1146/annurev.physiol.59.1.575.
32. Ingber, D.E. 2002. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res. 91(10): 877-887. doi:10.1161/01.RES. 0000039537.73816.E5.
33. Iwatani, H., Tomida, K., Nagasawa, Y., Imai, E., Rakugi, H., and Isaka, Y. 2009. Massive and rapid left ventricular calcification. NDT Plus, 2(3): 259-260. doi:10.1093/ndtplus/sfp018.
34. Jeong, J.O., Han, J.W., Kim, J.M., Cho, H.J., Park, C., Lee, N., et al. 2011. Malignant tumor formation after transplantation of shortterm cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ. Res. 108(11): 1340-1347. doi:10.1161/CIRCRESAHA.110.239848.
35. Kim, M.S., Lee, C.S., Hur, J., Cho, H.J., Jun, S.I., Kim, T.Y., et al. 2009. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway. Circulation, 120(22): 2240-2250. doi:10.1161/CIRCULATIONAHA.109.856815.
36. Klemke, R.L., Cai, S., Giannini, A.L., Gallagher, P.J., de Lanerolle, P., and Cheresh, D.A. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137(2): 481-492. doi:10.1083/jcb.137.2.481.
37. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., Takuma, S., Burkhoff, D., Wang, J., et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7(4): 430-436. doi:10.1038/86498.
38. Krenning, G. 2009. Endothelial progenitor cells in vascular regenerative medicine - towards 'designer blood vessels' and 'therapeutic neovascularization'. University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. ISBN: 978-90-367-3772-2.
39. Krenning, G., Dankers, P.Y.W., Jovanovic, D., van Luyn, M.J.A., and Harmsen, M.C. 2007. Efficient differentiation of CD14+ monocytic cells into endothelial cells on degradable biomaterials. Biomaterials, 28(8): 1470-1479. doi:10.1016/j.biomaterials.2006. 11.017.
40. Krenning, G., Moonen, J.R.A.J., van Luyn, M.J.A., and Harmsen, M. C. 2008. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials, 29(27): 3703-3711. doi:10.1016/j.biomaterials.2008.05.034.
41. Krenning, G., Dankers, P.Y., Drouven, J.W., Waanders, F., Franssen, C.F., van Luyn, M.J., et al. 2009a. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am. J. Physiol. Renal Physiol. 296(6): F1314-F1322. doi:10.1152/ajprenal.90755.2008.
42. Krenning, G., van der Strate, B.W.A., Schipper, M., van Seijen, X.J., Fernandes, B.C., van Luyn, M.J., and Harmsen, M.C. 2009b. CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J. Cell. Mol. Med. 13(8b): 2521-2533. doi:10.1111/j.1582-4934.2008.00479.x.
43. Krenning, G., van Luyn, M.J.A., and Harmsen, M.C. 2009c. Endothelial progenitor cell-based neovascularization: Implications for therapy. Trends Mol. Med. 15(4): 180-189. doi:10.1016/j.molmed.2009.02.001.
44. Krenning, G., Zeisberg, E.M., and Kalluri, R. 2010. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 225 (3): 631-637. doi:10.1002/jcp.22322.
45. Krenning, G., van der Strate, B.W.A., Schipper, M., Brouwer, L.A., Fernandes, B.C.A., van Luyn, M.J.A., et al. 2011. Combined implantation of CD34+ and CD14+ cells increases neovascularization through amplified paracrine signaling. J. Tissue Eng. Regen. Med., In press. doi:10.1002/term.503.
46. Ku, D.N., Giddens, D.P., Zarins, C.K., and Glagov, S. 1985. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis, 5(3): 293-302. doi:10.1161/01.ATV.5.3.293.
47. Liu, J.W., Dunoyer-Geindre, S., Blot-Chabaud, M., Sabatier, F., Fish, R.J., Bounameaux, H., et al. 2010. Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer. J. Vasc. Res. 47(2): 157-167. doi:10.1159/000250094.
48. Masumura, T., Yamamoto, K., Shimizu, N., Obi, S., and Ando, J. 2009. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 29(12): 2125-2131. doi:10.1161/ATVBAHA.109.193185.
49. McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., and Chen, C.S. 2004. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell, 6(4): 483-495. doi:10.1016/S1534-5807(04)00075-9.
50. Medici, D., Shore, E.M., Lounev, V.Y., Kaplan, F.S., Kalluri, R., and Olsen, B.R. 2010. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat. Med. 16(12): 1400-1406. doi:10.1038/nm.2252.
51. Medici, D., Potenta, S., and Kalluri, R. 2011. Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smadindependent signalling. Biochem. J. 437(3): 515-520. doi:10.1042/BJ20101500.
52. Moonen, J.R.A.J., de Leeuw, K., van Seijen, X., Kallenberg, C., van Luyn, M.J.A., Bijl, M., and Harmsen, M.C. 2007. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 9 (4): R84. doi:10.1186/ar2283.
53. Moonen, J.R.A.J., Krenning, G., Brinker, M.G.L., Koerts, J.A., van Luyn, M.J.A., and Harmsen, M.C. 2010. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc. Res. 86(3): 506-515. doi:10.1093/cvr/cvq012.
54. Mouquet, F., Lemesle, G., Delhaye, C., Charbonnel, C., Ung, A., Corseaux, D., et al. 2011. The presence of apoptotic bone marrow cells impairs the efficacy of cardiac cell therapy. Cell Transplant. 20(7): 1087-1097. doi:10.3727/096368910X544924.
55. Nan, J.L., Li, J.J., and He, J.G. 2009. C-reactive protein decreases interleukin-8 production in human endothelial progenitor cells by inhibition of p38 MAPK pathway. Chin. Med. J. (Engl.), 122(16): 1922-1928.
56. Obi, S., Yamamoto, K., Shimizu, N., Kumagaya, S., Masumura, T., Sokabe, T., et al. 2009. Fluid shear stress induces arterial differentiation of endothelial progenitor cells. J. Appl. Physiol. 106(1): 203-211. doi:10.1152/japplphysiol.00197.2008.
57. Okada, H., Takemura, G., Kosai, K., Tsujimoto, A., Esaki, M., Takahashi, T., et al. 2009. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure. Am. J. Physiol. Heart Circ. Physiol. 296 (3): H616-H626. doi:10.1152/ajpheart.01147.2008.
58. Olson, M.F., Ashworth, A., and Hall, A. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science, 269(5228): 1270-1272. doi:10.1126/science. 7652575.
59. Ong, L.L., Li, W., Oldigs, J.K., Kaminski, A., Gerstmayer, B., Piechaczek, C., et al. 2010. Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells. Tissue Eng. Part C Methods, 16(5): 1069-1081. doi:10.1089/ten.tec.2009.0641.
60. Palumbo, R., Gaetano, C., Melillo, G., Toschi, E., Remuzzi, A., and Capogrossi, M.C. 2000. Shear stress downregulation of plateletderived growth factor receptor-+f and matrix metalloprotease-2 is associated with inhibition of smooth muscle cell invasion and migration. Circulation, 102(2): 225-230.
61. Park, J.S., Chu, J.S., Cheng, C., Chen, F., Chen, D., and Li, S. 2004. Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol. Bioeng. 88(3): 359-368. doi:10.1002/bit.20250.
62. Pelham, R.J., Jr, and Wang, Y. 1997. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl. Acad. Sci. U.S.A. 94(25): 13661-13665. doi:10.1073/pnas.94.25.13661.
63. Ploeger, D.T.A., van Putten, S.M., Koerts, J.A., van Luyn, M.J.A., and Harmsen, M.C. 2011. Human macrophages primed with angiogenic factors show dynamic plasticity, irrespective of extracellular matrix components. Immunobiology, In press. doi:10.1016/j.imbio.2011.10.007.
64. Popa, E.R., Harmsen, M.C., Tio, R.A., van der Strate, B.W.A., Brouwer, L.A., Schipper, M., et al. 2006. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J. Mol. Cell. Cardiol. 41(1): 86-96. doi:10.1016/j.yjmcc. 2006.04.021.
65. Qi, Y.X., Jiang, J., Jiang, X.H., Wang, X.D., Ji, S.Y., Han, Y., et al. 2011. PDGF-BB and TGF-b1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc. Natl. Acad. Sci. U.S.A. 108(5): 1908-1913. doi:10.1073/pnas.1019219108.
66. Rastogi, S., Guerrero, M., Wang, M., Ilsar, I., Sabbah, M.S., Gupta, R.C., and Sabbah, H.N. 2011. Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs. Am. J. Physiol. Heart Circ. Physiol. 300(4): H1501-H1509. doi:10.1152/ajpheart.00636. 2010.
67. Robey, T.E., Saiget, M.K., Reinecke, H., and Murry, C.E. 2008. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45(4): 567-581. doi:10.1016/j.yjmcc.2008.03.009.
68. Saura, M., Zaragoza, C., Herranz, B., Griera, M., Diez-Marques, L., Rodriguez-Puyol, D., and Rodriguez-Puyol, M. 2005. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Circ. Res. 97(11): 1115-1123. doi:10.1161/01.RES.0000191538.76771.66.
69. Shimizu, N., Yamamoto, K., Obi, S., Kumagaya, S., Masumura, T., Shimano, Y., et al. 2008. Cyclic strain induces mouse embryonic stem cell differentiation into vascular smooth muscle cells by activating PDGF receptor beta. J. Appl. Physiol. 104(3): 766-772. doi:10.1152/japplphysiol.00870.2007.
70. Shiojima, I., Sato, K., Izumiya, Y., Schiekofer, S., Ito, M., Liao, R., et al. 2005. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115(8): 2108-2118. doi:10.1172/JCI24682.
71. Silva, E.A., Kim, E.S., Kong, H.J., and Mooney, D.J. 2008. Materialbased deployment enhances efficacy of endothelial progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 105(38): 14347-14352. doi:10.1073/pnas.0803873105.
72. Smart, N., Bollini, S., Dube, K.N., Vieira, J.M., Zhou, B., Davidson, S., et al. 2011. De novo cardiomyocytes from within the activated adult heart after injury. Nature, 474(7353): 640-644. doi:10.1038/nature10188.
73. Smits, A.M., van Laake, L.W., den Ouden, K., Schreurs, C., Szuhai, K., van Echteld, C.J., et al. 2009. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 83(3): 527-535. doi:10.1093/cvr/cvp146.
74. Stratman, A.N., Davis, M.J., and Davis, G.E. 2011. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood, 117(14): 3709-3719. doi:10.1182/blood-2010-11-316752.
75. Suzuki, K., Murtuza, B., Beauchamp, J.R., Brand, N.J., Barton, P.J., Varela-Carver, A., et al. 2004. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation, 110(11 Suppl. 1): II219-II224. doi:10.1161/01.CIR.0000138388.55416.06.
76. Terrovitis, J., Lautamäki, R., Bonios, M., Fox, J., Engles, J.M., Yu, J., et al. 2009. Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell Delivery. J. Am. Coll. Cardiol. 54(17): 1619-1626. doi:10.1016/j.jacc.2009.04.097.
77. Thomas, F.T., Contreras, J.L., Bilbao, G., Ricordi, C., Curiel, D., and Thomas, J.M. 1999. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery, 126(2): 299-304. doi:10.1016/S0039-6060(99)70169-8.
78. Thum, T., Bauersachs, J., Poole-Wilson, P.A., Volk, H.D., and Anker, S.D. 2005. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J. Am. Coll. Cardiol. 46(10): 1799-1802. doi:10.1016/j.jacc.2005.07.053.
79. Tomita, H., Egashira, K., Ohara, Y., Takemoto, M., Koyanagi, M., Katoh, M., et al. 1998. Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension, 32(2): 273-279.
80. Traub, O., and Berk, B.C. 1998. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler. Thromb. Vasc. Biol. 18(5): 677-685. doi:10.1161/01.ATV.18.5.677.
81. Tzima, E., Irani-Tehrani, M., Kiosses, W.B., Dejana, E., Schultz, D.A., Engelhardt, B., et al. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature, 437(7057): 426-431. doi:10.1038/nature03952.
82. Umar, S., and van der Laarse, A. 2010. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol. Cell. Biochem. 333(1-2): 191-201. doi:10.1007/s11010-009-0219-x.
83. van Amerongen, M.J., Harmsen, M.C., van Rooijen, N., Petersen, A.H., and van Luyn, M.J.A. 2007. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170(3): 818-829. doi:10.2353/ajpath.2007.060547.
84. van Amerongen, M.J., Bou-Gharios, G., Popa, E.R., van Ark, J., Petersen, A.H., van Dam, G.M., et al. 2008. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 214(3): 377-386. doi:10.1002/path.2281.
85. van der Strate, B.W.A., Popa, E.R., Schipper, M., Brouwer, L.A., Hendriks, M., Harmsen, M.C., and Vanluyn, M. 2007. Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model. J. Mol. Cell. Cardiol. 42(6): 1086-1097. doi:10.1016/j.yjmcc.2007.03.907.
86. Vandervelde, S., van Luyn, M.J.A., Tio, R.A., and Harmsen, M.C. 2005. Signaling factors in stem cell-mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39(2): 363-376. doi:10.1016/j.yjmcc.2005.05.012.
87. Vandervelde, S., van Amerongen, M.J., Tio, R.A., Petersen, A.H., van Luyn, M.J.A., and Harmsen, M.C. 2006. Increased inflammatory response and neovascularization in reperfused vs. nonreperfused murine myocardial infarction. Cardiovasc. Pathol. 15 (2): 83-90. doi:10.1016/j.carpath.2005.10.006.
88. Vandervelde, S., van Luyn, M.J.A., Rosenbaum, M.H., Petersen, A.H., Tio, R.A., and Harmsen, M.C. 2007. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc. Res. 73(4): 783-793. doi:10.1016/j.cardiores.2006.11.030.
89. Verma, S., Kuliszewski, M.A., Li, S.H., Szmitko, P.E., Zucco, L., Wang, C.H., et al. 2004. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation, 109(17): 2058-2067. doi:10.1161/01.CIR.0000127577.63323.24.
90. von der Mark, K., Park, J., Bauer, S., and Schmuki, P. 2010. Nanoscale engineering of biomimetic surfaces: cues from the extracellular matrix. Cell Tissue Res. 339(1): 131-153. doi:10.1007/s00441-009-0896-5.
91. Weeke-Klimp, A., Bax, N.A., Bellu, A.R., Winter, E.M., Vrolijk, J., Plantinga, J., et al. 2010. Epicardium-derived cells enhance proliferation, cellular maturation and alignment of cardiomyocytes. J. Mol. Cell. Cardiol. 49(4): 606-616. doi:10.1016/j.yjmcc.2010.07.007.
92. Werner, N., and Nickenig, G. 2006. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler. Thromb. Vasc. Biol. 26(2): 257-266. doi:10.1161/01.ATV.0000198239.41189.5d.
93. Winter, E.M., van Oorschot, A.A., Hogers, B., van der Graaf, L.M., Doevendans, P.A., Poelmann, R.E., et al. 2009. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Circ. Heart Fail. 2(6): 643-653. doi:10.1161/CIRCHEARTFAILURE.108.843722.
94. Xu, Z., Castellino, F.J., and Ploplis, V.A. 2010. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood, 115(10):2038-2047. doi:10.1182/blood-2009-09-244962.
95. Yamamoto, K., Takahashi, T., Asahara, T., Ohura, N., Sokabe, T., Kamiya, A., and Ando, J. 2003. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol. 95(5): 2081-2088.
96. Yamamoto, K., Sokabe, T., Watabe, T., Miyazono, K., Yamashita, J.K., Obi, S., et al. 2005. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am. J. Physiol. Heart Circ. Physiol. 288(4): H1915-H1924. doi:10.1152/ajpheart.00956. 2004.
97. Yoder, M.C., Mead, L.E., Prater, D., Krier, T.R., Mroueh, K.N., Li, F., et al. 2007. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109(5): 1801-1809. doi:10.1182/blood-2006-08-043471.
98. Yoon, Y.S., Park, J.S., Tkebuchava, T., Luedeman, C., and Losordo, D.W. 2004. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation, 109(25): 3154-3157. doi:10.1161/01.CIR.0000134696.08436.65.
99. Younce, C.W., and Kolattukudy, P.E. 2010. MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zincfinger protein, MCPIP. Biochem. J. 426(1): 43-53. doi:10.1042/BJ20090976.
100. Younce, C.W., Wang, K., and Kolattukudy, P.E. 2010. Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc. Res. 87(4): 665-674. doi:10.1093/cvr/cvq102.
101. Zemani, F., Silvestre, J.S., Fauvel-Lafeve, F., Bruel, A., Vilar, J., Bieche, I., et al. 2008. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler. Thromb. Vasc. Biol. 28(4): 644-650. doi:10.1161/ATVBAHA.107.160044.
102. Zeng, L., Hu, Q., Wang, X., Mansoor, A., Lee, J., Feygin, J., et al. 2007. Bioenergetic and functional consequences of bone marrowderived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation, 115(14): 1866-1875. doi:10.1161/CIRCULATIONAHA.106.659730.
103. Zhang, Y., Ingram, D.A., Murphy, M.P., Saadatzadeh, M.R., Mead, L.E., Prater, D.N., and Rehman, J. 2009. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 296(5): H1675-H1682. doi:10.1152/ajpheart.00665.2008.
104. Zhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F.M., et al. 2006. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98(9): 1177-1185. doi:10.1161/01.RES.0000220106.64661.71.
105. Zhou, X., Liu, Y., You, J., Zhang, H., Zhang, X., and Ye, L. 2008. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett. 270(2): 312-327. doi:10.1016/j.canlet.2008.05.028.
106. Zymek, P., Bujak, M., Chatila, K., Cieslak, A., Thakker, G., Entman, M.L., and Frangogiannis, N.G. 2006. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J. Am. Coll. Cardiol. 48(11): 2315-2323. doi:10.1016/j.jacc.2006.07.060.